INFLUENCE OF INTERLEUKIN-6 ON NEURAL ACTIVITY AND TRANSCRIPTION OF THE GENE ENCODING CORTICOTROPIN-RELEASING FACTOR IN THE RAT-BRAIN - AN EFFECT DEPENDING UPON THE ROUTE OF ADMINISTRATION
L. Vallieres et al., INFLUENCE OF INTERLEUKIN-6 ON NEURAL ACTIVITY AND TRANSCRIPTION OF THE GENE ENCODING CORTICOTROPIN-RELEASING FACTOR IN THE RAT-BRAIN - AN EFFECT DEPENDING UPON THE ROUTE OF ADMINISTRATION, European journal of neuroscience, 9(7), 1997, pp. 1461-1472
Interleukin-6 (IL-6) is a pleiotropic cytokine produced by Various lym
phoid and neural cells. In addition to its classic role during immune
and inflammatory responses, IL-6 acts on the central nervous system to
elicit changes, such as activation of the hypothalamic-pituitary-adre
nal (HPA) axis. This study investigated the effects of systemic and ce
ntral injection of IL-6 on neural activity and transcription of the co
rticotrophin-releasing factor (CRF) gene in the brain of conscious rat
s. The animals were killed 1 and 3 h after a single infusion of IL-6 i
nto the right jugular vein (0.83 or 3.0 mu g) or the right lateral ven
tricle (0.2 mu g) and their brains cut from the olfactory bulb to the
end of the medulla in 30-mu m coronal sections. Messenger RNA encoding
the protein Fos, a marker of neural activity, and the neuropeptide CR
F were localized by in situ hybridization histochemistry using S-35-la
belled exonic and intronic riboprobes. The results show that systemic
injection of IL-6 induced specific transcription of c-fos gene in most
of the sensorial circumventricular organs, including the organum vasc
ulosum lamina terminalis, subfornical organ, median eminence, and area
postrema, as well as in the central nucleus of the amygdala and bed n
ucleus of the stria terminalis. On the other hand, central injection o
f IL-6 increased cellular level of c-fos mRNA in the ependymal layer a
nd the walls of the ventricles, meninges, nucleus of the solitary trac
t, and circumventricular organs. These effects were rapid and transien
t, since the signals for c-fos mRNA were detected I h after both treat
ments and vanished 3 h afterwards. Moreover, the CRF gene was not acti
vated by either systemic or central administration of IL-6 in the para
ventricular nucleus of the hypothalamus. Taken together, these results
suggest that circumventricular organs hold a privileged position in m
ediating the central effects of systemic IL-6 and that centrally injec
ted IL-6 can strongly activate cells of the ventricular system and sur
rounding structures. Although this differential circuitry may explain
distinct origin-dependent functions of IL-6, this cytokine seems insuf
ficient, in itself, to induce transcription of the gene encoding neuro
endocrine CRF, the neuropeptide responsible for control of the HPA axi
s.